TREATMENT WITH TOCILIZUMAB IMPROVED RHEUMATOID ARTHRITIS PATIENTS CLINICALLY AND STRUCTURALLY REGARDLESS OF THE PRIOR USE OF ANTI-TNF BIOLOGICS IN DAILY CLINICAL PRACTICE

被引：0
|
作者：
Izumi, K. [1 ]
Kaneko, Y. [1 ]
Yasuoka, H. [1 ]
Seta, N. [1 ]
Kameda, H. [1 ]
Kuwana, M. [1 ]
Takeuchi, T. [1 ]
机构：
[1] Keio Univ, Sch Med, Dept Internal Med, Div Rheumatol, Tokyo, Japan
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2013年 / 72卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：884 / 885
页数：2
相关论文
共 50 条
  • [1] Clinical evaluation of tocilizumab for patients with active rheumatoid arthritis refractory to anti-TNF biologics: tocilizumab in combination with methotrexate
    Nakashima, Yasuharu
    Kondo, Masakazu
    Harada, Hiroshi
    Horiuchi, Takahiko
    Ishinishi, Takashi
    Jojima, Hiroshi
    Kuroda, Koji
    Miyahara, Hisaaki
    Nagamine, Ryuji
    Nakashima, Hitoshi
    Otsuka, Takeshi
    Saikawa, Isao
    Shono, Eisuke
    Suematsu, Eiichi
    Tsuru, Tomomi
    Wada, Ken
    Iwamoto, Yukihide
    [J]. MODERN RHEUMATOLOGY, 2010, 20 (04) : 343 - 352
  • [2] Maintenance of anti-TNF agents in rheumatoid arthritis patients in daily practice
    Schaeverbeke, T
    Dumoulin, C
    Richez, C
    Mehsen, N
    Bentaberry, F
    Monnier, A
    Dehais, J
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2004, 63 : 301 - 301
  • [3] Remission for rheumatoid arthritis patients on anti-TNF in clinical practice
    Murphy, Kevin
    Butt, Sayqa
    Gadsby, Kate
    Deighton, Chris
    [J]. RHEUMATOLOGY, 2008, 47 : II40 - II40
  • [4] The agreement with the dutch regulation for reimbursement of anti-TNFα for patients with rheumatoid arthritis in daily clinical practice discussed
    Kievit, W.
    Adang, E. M.
    Franssen, J.
    Kuper, I. H.
    van de Laar, M. A. F. J.
    de Rooij, D. R. A. M.
    De Gendt, C. M. A.
    Janssens, T. L.
    van Ooijen, P. C. M.
    Brus, H. L. M.
    van Riel, P. L. C. M.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2007, 66 : 264 - 264
  • [5] Maintenance rates of anti-TNF agents in rheumatoid arthritis patients in daily practice.
    Dumoulin, C
    Richez, C
    Mehsen, N
    Bentaberry, F
    Monnier, A
    Dehais, J
    Schaeverbeke, T
    [J]. ARTHRITIS AND RHEUMATISM, 2004, 50 (09): : S398 - S398
  • [6] Pharmacogenetics of anti-TNF treatment in patients with rheumatoid arthritis
    Coenen, Marieke J. H.
    Toonen, Erik J. M.
    Scheffer, Hans
    Radstake, Timothy R. D. J.
    Barrera, Pilar
    Franke, Barbara
    [J]. PHARMACOGENOMICS, 2007, 8 (07) : 761 - 773
  • [7] LTBI screening in rheumatoid arthritis patients prior to anti-TNF treatment in an endemic area
    Bonfiglioli, K. R.
    Ribeiro, A. C. M.
    Moraes, J. C. B.
    Saad, C. G. S.
    Souza, F. H. C.
    Calich, A. L.
    Bonfa, E.
    Laurindo, I. M. M.
    [J]. INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE, 2014, 18 (08) : 905 - 911
  • [8] LONG-TERM TOCILIZUMAB TREATMENT IN PATIENTS WITH RHEUMATOID ARTHRITIS IN DAILY CLINICAL PRACTICE
    Ono, Y.
    Hirano, Y.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2022, 81 : 1296 - 1296
  • [9] Clinical parameters and biomarkers for anti-TNF treatment prognosis in rheumatoid arthritis patients
    Cuchacovich, Miguel
    Bueno, Daniel
    Carvajal, Rodrigo
    Bravo, Nicolas
    Carlos Aguillon, Juan
    Catalan, Diego
    Soto, Lilian
    [J]. CLINICAL RHEUMATOLOGY, 2014, 33 (12) : 1707 - 1714
  • [10] Clinical parameters and biomarkers for anti-TNF treatment prognosis in rheumatoid arthritis patients
    Miguel Cuchacovich
    Daniel Bueno
    Rodrigo Carvajal
    Nicolás Bravo
    Juan Carlos Aguillón
    Diego Catalán
    Lilian Soto
    [J]. Clinical Rheumatology, 2014, 33 : 1707 - 1714
12345